Dear colleagues and friends, 
 

Incidence of valvular heart diseases keeps increasing along with the aging trend of the world, and makes it a serious threat to human health. As the evidence accumulates, transcatheter valvular replacement/repair emerged as an alternative for traditional cardiac surgery, especially in the field of transcatheter aortic valve replacement (TAVR). However, development of transcatheter valvular treatment in China is still at the initial status. There is an urgent call for systemic training for Chinese interventional cardiologists and their heart valve teams. 

 

As we all know, CSI (Catheter Interventions in Congenital, Structural and Valvular Heart Disease) is one of the leading conferences in the field of transcatheter valvular treatment. This year China Valve (Hangzhou) will work with the support of CSI to provide a broader global vision, an improved training course and a deeper communicative platform on 25th to 27th March 2016. The program will include step by step live cases, hands-on sessions, imaging training, device designs and up-to-date clinical trials. 

 

Hangzhou is an ancient, yet highly civilized city rich in both historical sites and natural landscapes, such as the West Lake and Grand Canal. The city is also an international metropolis where the G20 summit will be held in September 2016. You will have the opportunity to enjoy the wonderful scenery after scientific activities. 

 

Welcome to Hangzhou!